KELLANOVA Quarterly Revenues in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Kellanova quarterly/annual Revenues history and growth rate from Q1 2017 to Q3 2024.
  • Kellanova Revenues for the quarter ending September 28, 2024 was $3.23B, a 0.68% decline year-over-year.
  • Kellanova Revenues for the twelve months ending September 28, 2024 was $12.8B, a 2.39% decline year-over-year.
  • Kellanova annual Revenues for 2023 was $13.1B, a 3.71% increase from 2022.
  • Kellanova annual Revenues for 2022 was $12.7B, a 7.71% increase from 2021.
  • Kellanova annual Revenues for 2021 was $11.7B, a 14.7% decline from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $12.8B $3.23B -$22M -0.68% Jun 30, 2024 Sep 28, 2024 10-Q 2024-10-31
Q2 2024 $12.8B $3.19B -$159M -4.75% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-01
Q1 2024 $13B $3.2B -$142M -4.25% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-02
Q4 2023 $13.1B $3.17B +$10M +0.32% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-20
Q3 2023 $13.1B $3.26B +$4M +0.12% Jul 2, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $13.1B $3.35B +$170M +5.34% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-01
Q1 2023 $12.9B $3.34B +$285M +9.32% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-02
Q4 2022 $12.7B $3.16B +$2.18B +221% Oct 2, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $10.5B $3.25B -$371M -10.2% Jul 3, 2022 Oct 1, 2022 10-K 2024-02-20
Q2 2022 $10.8B $3.18B -$374M -10.5% Apr 3, 2022 Jul 2, 2022 10-K 2024-02-20
Q1 2022 $11.2B $3.06B -$527M -14.7% Jan 2, 2022 Apr 2, 2022 10-K 2024-02-20
Q4 2021 $11.7B $986M -$2.48B -71.5% Oct 3, 2021 Jan 1, 2022 10-K 2024-02-20
Q3 2021 $14.2B $3.62B +$193M +5.63% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-03
Q2 2021 $14B $3.56B +$90M +2.6% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-04
Q1 2021 $13.9B $3.58B +$172M +5.04% Jan 3, 2021 Apr 3, 2021 10-Q 2022-05-05
Q4 2020 $13.8B $3.46B +$241M +7.48% Sep 27, 2020 Jan 2, 2021 10-K 2021-02-22
Q3 2020 $13.5B $3.43B +$57M +1.69% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-05
Q2 2020 $13.5B $3.47B +$4M +0.12% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-06
Q1 2020 $13.5B $3.41B -$110M -3.12% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-07
Q4 2019 $13.6B $3.22B -$94M -2.83% Sep 29, 2019 Dec 28, 2019 10-K 2021-02-22
Q3 2019 $13.7B $3.37B -$97M -2.8% Jun 30, 2019 Sep 28, 2019 10-K 2021-02-22
Q2 2019 $13.8B $3.46B +$101M +3.01% Mar 31, 2019 Jun 29, 2019 10-K 2021-02-22
Q1 2019 $13.7B $3.52B +$121M +3.56% Dec 30, 2018 Mar 30, 2019 10-K 2021-02-22
Q4 2018 $13.5B $3.32B +$132M +4.14% Sep 30, 2018 Dec 29, 2018 10-K 2020-02-24
Q3 2018 $13.4B $3.47B +$223M +6.87% Jul 1, 2018 Sep 29, 2018 10-K 2020-02-24
Q2 2018 $13.2B $3.36B +$185M +5.83% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-24
Q1 2018 $13B $3.4B +$153M +4.71% Dec 31, 2017 Mar 31, 2018 10-K 2020-02-24
Q4 2017 $12.9B $3.19B Oct 1, 2017 Dec 30, 2017 10-K 2019-02-25
Q3 2017 $3.25B Jul 2, 2017 Sep 30, 2017 10-K 2019-02-25
Q2 2017 $3.18B Apr 2, 2017 Jul 1, 2017 10-K 2019-02-25
Q1 2017 $3.25B Jan 1, 2017 Apr 1, 2017 10-K 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.